Top News: Last 7 Days
- After burning nearly $700M over 2 decades, Peninsula biotech looks at ‘strategic alternatives’
- In race to defeat fatty liver disease, Peninsula biotech lines up next clinical trial
- A new study points to $6.5B in public support building the scientific foundation of Gilead’s remdesivir. Should that be reflected in the price?
- Trump and Navarro press again for hydroxychloroquine. Can the FDA stay independent?
- Pharmacy startup raises $25M to become the digital prescription backbone for virtual health
- Vir Biotechnology Appoints Elliott Sigal, M.D., Ph.D. to Board of Directors
- Paragon Genomics Readies Higher Throughput Version of Its Popular CleanPlex® SARS-CoV-2 NGS Panel Amid Growing Need for Large-Scale COVID-19 Testing
- GSK sets the stage for a toe-to-toe market showdown with Gilead’s HIV champion Truvada
- Takeda and the New York Academy of Sciences Announce 2020 Innovators in Science Award Winners
- 89bio Announces Pricing of Upsized Public Offering of Common Stock
See All News
Top Jobs: Last 30 Days
- Clinical Data Manager – Karius – Redwood City, CA
- Marketing Intern (719) – Amyris, Inc. – Emeryville, CA
- Oncology Account Manager – Northeast | Philadelphia, PA – Oncopeptides North America – Los Altos, CA
- Entry Level Environmental Specialist (San Francisco/Oakland)
- Research Associate II/ Sr. Research Associate, Protein Purification | Astellas | South San Francisco, CA
- Vivarium Manager – BioAge Labs – Richmond, CA
- Product Development Intern (Biossance) (716) – Amyris, Inc. – Emeryville, CA
- Internship at Mango Materials (redwood shores)
- Scientific Project Manager – Epidemiology Vitalant Research Institute
- Bioinformatics Intern, Metagenomics – Second Genome – South San Francisco, CA
